6-CARBOXYFLUORESCEIN DIACETATE
|
|
- CAS-Nr.
- 3348-03-6
- Englisch Name:
- 6-CARBOXYFLUORESCEIN DIACETATE
- Synonyma:
- 3TFA;6-CFDA;NSC3410;6-FAM DA;NSC 3410;NSC-3410;3TFA ≥6-fam(Ac2);~95% (HPLC);Abafungin &ge
- CBNumber:
- CB4669199
- Summenformel:
- C25H16O9
- Molgewicht:
- 460.39
- MOL-Datei:
- 3348-03-6.mol
|
6-CARBOXYFLUORESCEIN DIACETATE Eigenschaften
- Schmelzpunkt:
- 152–153°C
- Siedepunkt:
- 701.6±60.0 °C(Predicted)
- Dichte
- 1.57±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- L?slichkeit
- DMSO: soluble
- pka
- 6.4(at 25℃)
- Aggregatzustand
- Solid
- Farbe
- Light yellow or off-white solid
- S?ure-Base-Indikators(pH-Indikatoren)
- Weak green ' uorescence (6.0) to strong green ' uourescence (7.2)
- maximale Wellenl?nge (λmax)
- <300nm
- Major Application
- Fluorescent probes, detecting cells, microorganisms, yeasts, antifungal agent, antibacterials agent
- Biologische Anwendungen
- Analyzing/detecting
cells;counting/
detecting/evaluating microorganisms;detecting/
measuring bacteria;quantifying adhesion of
tumor cells to endothelial monolayers;
measuring
gas (carbon dioxide or ammonia) concentration
in body luids;
monitoring intracellular nitric
oxide production;screening xenobiotic phloem
mobility in plants;
, studying low-density
lipoprotein (LDL)/cholesterol metabolism;apoptosis
assay;method for antifungal susceptibility
testing;
, as a substrate for measuring esterase
activity
- CAS Datenbank
- 3348-03-6(CAS DataBase Reference)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
WGK Germany |
3 |
|
|
F |
10-21 |
|
|
HS Code |
29322090 |
|
|
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
|
|
Sicherheit |
P261 |
Einatmen von Staub vermeiden. |
P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
6-CARBOXYFLUORESCEIN DIACETATE Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
6-CARBOXYFLUORESCEIN DIACETATE is used to differentiate viable cells from apoptotic cells. Live cells that are not apoptotic accumulate 6-carboxyfluorescein but do not accumulate annexin
6-CARBOXYFLUORESCEIN DIACETATE Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
6-CARBOXYFLUORESCEIN DIACETATE Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 151)Lieferanten
3348-03-6()Verwandte Suche:
- BIOCHEMIKA, FOR FLUORESCENCE, ≥90.0% (HPLC)
- ~95% (HPLC)
- 6-Carboxy-di-O-acetylfluorescein, 6-CFDA
- 3',6'-Bis(acetyloxy)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid
- 3',6'-Diacetoxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid
- 3-Oxo-3',6'-diacetoxyspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid
- 6-CARBOXYFLUORESCEIN DIACETATE
- 6-CARBOXY-DI-O-ACETYLFLUORESCEIN
- 6-CARBOXYFLUORESCEINE DIACETATE
- 6-CFDA
- 6-FAM DIACETATE
- 3',6'-diacetoxy-1-keto-spiro[isobenzofuran-3,9'-xanthene]-5-carboxylic acid
- 3',6'-diacetyloxy-1-oxo-spiro[2-benzofuran-3,9'-xanthene]-5-carboxylic acid
- 3',6'-diacetyloxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carboxylic acid
- 6-Carboxyfluorescein diacetate,6-CFDA, 6-Carboxy-di-O-acetylfluorescein
- 6-FAM DA
- 3',6'-Diacetoxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-6-carboxylic acid
- 6-CFDA [6-Carboxyfluorescein diacetate]
- Spiro[phthalan-1,9′-xanthene]-6-carboxylic Acid, 3′,6′-dihydroxy-3-oxo-, Diacetate
- Terephthalic acid, (3,6,9-trihydroxyxanthen-9-yl)-, Γ-lactone, diacetate
- 6-carboxy' Uoresceindiacetate
- 1H-Indole-7-carbohydrazide &ge
- D-Hydroorotic acid &ge
- 6-Bromo-3-methylindazole &ge
- 5-Benzyloxy-1H-indazole &ge
- Acetyl-L-cystine &ge
- 6-Bromopyridine-2,3-diamine &ge
- Ethyl 4-amino-2-(methylthio)-1,3-thiazole-5-carboxylate &ge
- Ethyl 2-chloroxazole-4-carboxylate &ge
- 6-Bromoimidazo[1,2-a]pyridin-8-amine &ge
- 2-Methoxy-pyridin-4-ylamine &ge
- -Boc-amino)-guanidino]-pentanoic acid &ge
- Fmoc-L-2-amino-5-phenylpentanoic acid &ge
- 2-Fluoropyridine-4-boronic acid &ge
- -trifluoroethyl-guanidino)-pentanoic acid
- 6-Bromo-2,5-dioxo-1,2,5,6,7,8-hexahydroquinoline-3-carbonitrile &ge
- 2-Cyano-3-Trifluoromethylpyridine &ge
- -monophosphate monohydrate &ge
- Z-D-Ala-Gly-OH &ge
- Spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid, 3',6'-bis(acetyloxy)-3-oxo-
- NSC 3410
- NSC3410
- NSC-3410
- Fmoc-di-n-butylglycine &ge
- 2-Methoxy-5-nitropyridin-4-amine &ge
- 6-Bromo-2-methylindazole &ge
- (S)-3-Hydroxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester &ge
- 1-Methyl-pyrrolidine-3-carboxylic acid &ge
- 2-(2-Aminophenyl)oxazole-4-carboxylic acid ethyl ester &ge
- Fmoc-1(1-Boc-piperidin-4-yl)-DL-glycine &ge
- Fmoc-(R)-3-amino-3-(2-nitrophenyl)propionic acid &ge
- 1-(3-Chloropropyl)-4-methylpiperazine dihydrochloride &ge
- 4-Bromo-3,5-dimethylpyridine hydrochloride &ge
- 1H-Indazole-6-carboxylic acid &ge
- (6-Methyl-Pyridin-2-yl)-carbamic acid tert-butyl ester &ge
- 2-Chloro-6-methoxy-quinoline &ge
- 4-Phenyl-thiazole-2-carboxylic acid ethyl ester &ge
- 5-Methyloxazole-4-carboxylic acid &ge